THE SUMMIT TEAM

Colin focuses primarily on the technology sector. His investments include Advanced Cell Diagnostics (acquired by Bio-Techne Corporation), Delphix, Gainsight, InfoArmor, Jamf, onX, Podium, Reverb.com, RiskIQ, Rocket Fuel (NASDAQ: FUEL), TeleSign (acquired by BICS), TSheets (acquired by Intuit), Uber and Wowza Media Systems.

Prior to Summit, Colin worked for Union Square Advisors, Accenture and Electronic Arts. He holds a BS in finance and marketing, with High Honors, from Lehigh University.

Related Perspectives
• “Backing Bootstrapped Companies in the Mountain West – Our Investment in onX”